{"width":"100%","provider_url":"https://hatena.blog","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20111228%2Fp3\" title=\"\u8b66\u544a\u6587\u66f8 - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","url":"https://uneyama.hatenadiary.jp/entry/20111228/p3","author_name":"uneyama","image_url":null,"title":"\u8b66\u544a\u6587\u66f8","description":"Posted on December 27, 2011 NeuroScience, Inc. 12/19/11 http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2011/ucm284391.htm \u30b5\u30d7\u30ea\u30e1\u30f3\u30c8\u88fd\u54c1\u306b\u300cmedical food\u300d\u3068\u8868\u793a\u3001\u3053\u308c\u306f\u533b\u5e2b\u306e\u76e3\u8996\u4e0b\u3067\u306e\u307f\u4f7f\u3048\u308b\u3082\u306e\u3092\u610f\u5473\u3059\u308b\u3002\u3055\u3089\u306b\u88fd\u54c1\u306e\u5ba3\u4f1d\u6587\u53e5\u300c\u708e\u75c7\u6027\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u3092\u8abf\u7bc0\u300d\u300c\u75db\u307f\u3092\u548c\u3089\u3052\u308b\u300d\u300c\u9ad8\u8840\u5727\u306b\u300d\u306a\u3069\u306f\u533b\u85ac\u54c1\u3068\u307f\u306a\u3055\u308c\u308b\u3002 Atlantic Pro Nutrients, Inc. dba XYMOGEN 12/13/11 http://www.fd\u2026","version":"1.0","categories":["FDA"],"type":"rich","author_url":"https://blog.hatena.ne.jp/uneyama/","published":"2011-12-28 00:00:02","provider_name":"Hatena Blog","height":"190","blog_url":"https://uneyama.hatenadiary.jp/"}